Agilent Technologies, Inc. $A Stock Purchased by Lmcg Investments LLC

Lmcg Investments LLC lifted its holdings in Agilent Technologies, Inc. (NYSE:A) by 6.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 105,340 shares of the medical research company’s stock after buying an additional 6,117 shares during the quarter. Agilent Technologies makes up about 1.0% of Lmcg Investments LLC’s portfolio, making the stock its 29th biggest position. Lmcg Investments LLC’s holdings in Agilent Technologies were worth $18,151,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of A. State Street Corp boosted its holdings in Agilent Technologies by 0.7% during the 2nd quarter. State Street Corp now owns 12,854,230 shares of the medical research company’s stock valued at $1,710,658,000 after acquiring an additional 89,598 shares during the period. Wellington Management Group LLP grew its position in Agilent Technologies by 2.7% in the 2nd quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company’s stock valued at $990,206,000 after acquiring an additional 198,253 shares during the last quarter. Deutsche Bank AG grew its position in Agilent Technologies by 17.1% in the 2nd quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock valued at $930,957,000 after acquiring an additional 1,024,516 shares during the last quarter. Bank of New York Mellon Corp increased its stake in Agilent Technologies by 87.4% in the second quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after purchasing an additional 2,440,360 shares during the period. Finally, Legal & General Group Plc purchased a new stake in Agilent Technologies in the second quarter worth $260,101,000.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $151.38, for a total transaction of $95,974.92. Following the transaction, the director directly owned 4,924 shares in the company, valued at $745,395.12. This represents a 11.41% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Analyst Ratings Changes

Several analysts have recently weighed in on A shares. Jefferies Financial Group initiated coverage on Agilent Technologies in a research report on Thursday, July 9th. They set a “hold” rating and a $135.00 target price for the company. UBS Group initiated coverage on shares of Agilent Technologies in a research note on Wednesday, September 9th. They set a “neutral” rating and a $165.00 target price for the company. JPMorgan Chase & Co. upped their price target on shares of Agilent Technologies from $180.00 to $190.00 and gave the stock an “overweight” rating in a report on Thursday, August 27th. TD Cowen upped their price target on shares of Agilent Technologies from $180.00 to $196.00 and gave the stock a “buy” rating in a report on Tuesday, October 13th. Finally, Morgan Stanley raised their price target on shares of Agilent Technologies from $175.00 to $190.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 13th. Fifteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, Agilent Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $173.65.

Agilent Technologies Trading Up 2.8%

Shares of NYSE A opened at $177.93 on Thursday. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. The business has a fifty day simple moving average of $160.50 and a two-hundred day simple moving average of $138.97. The firm has a market cap of $50.16 billion, a PE ratio of 35.03, a price-to-earnings-growth ratio of 2.63 and a beta of 1.21. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $178.21.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The business had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same quarter in the prior year, the company earned $1.37 EPS. The business’s revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Analysts expect that Agilent Technologies, Inc. will post 6.20 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 28th. Shareholders of record on Tuesday, October 6th will be issued a dividend of $0.2550 per share. This represents a $1.02 annualized dividend and a yield of 0.6%. The ex-dividend date is Tuesday, October 6th. Agilent Technologies’s dividend payout ratio is presently 20.08%.

Agilent Technologies Profile

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.